Dusseldorf - Delayed Quote • EUR X4 Pharmaceuticals Inc (48Q.DU) Follow Add holdings 0.0000 0.0000 +(4.13%) As of April 25 at 7:31:52 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 48Q.DU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 48Q.DU View More All News Press Releases SEC Filings X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates Why X4 Pharmaceuticals, Inc. (XFOR) is Surging in 2025 X4 Pharmaceuticals to Report First-Quarter 2025 Financial Results and Host Conference Call and Webcast on May 1, 2025 X4 Pharmaceuticals Announces Reverse Stock Split X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) XFOR: Full Enrollment of Phase 3 4WARD Trial Expected in 2H25… X4 Pharmaceuticals Inc (XFOR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... Q4 2024 X4 Pharmaceuticals Inc Earnings Call X4 Pharmaceuticals: Q4 Earnings Snapshot X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year 2024 Financial Results and Host a Conference Call and Webcast on March 25, 2025